BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25432323)

  • 1. Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome.
    Laux CJ; Berzaczy G; Weber M; Lang S; Dominkus M; Windhager R; Nöbauer-Huhmann IM; Funovics PT
    Int Orthop; 2015 Jan; 39(1):97-104. PubMed ID: 25432323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI for evaluation of preoperative chemotherapy in osteosarcoma.
    Yildirim O; Al Khatalin M; Kargin OA; Camurdan VB
    Radiography (Lond); 2022 Aug; 28(3):593-604. PubMed ID: 35537246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.
    Uhl M; Saueressig U; Koehler G; Kontny U; Niemeyer C; Reichardt W; Ilyasof K; Bley T; Langer M
    Pediatr Radiol; 2006 Dec; 36(12):1306-11. PubMed ID: 17031633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.
    Huang B; Wang J; Sun M; Chen X; Xu D; Li ZP; Ma J; Feng ST; Gao Z
    BMC Cancer; 2020 Apr; 20(1):322. PubMed ID: 32293344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
    Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
    Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
    Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
    J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
    Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
    Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
    Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
    J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction of chemotherapy response in primary osteosarcoma using the machine learning technique on radiomic data].
    Dufau J; Bouhamama A; Leporq B; Malaureille L; Beuf O; Gouin F; Pilleul F; Marec-Berard P
    Bull Cancer; 2019 Nov; 106(11):983-999. PubMed ID: 31587802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.
    Jeon DG; Song WS; Cho WH; Kong CB; Cho SH
    Clin Orthop Relat Res; 2014 Jun; 472(6):1911-20. PubMed ID: 24574120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dynamic MRI and clinical assessment in predicting histologic response to neoadjuvant chemotherapy in bone sarcomas.
    Amit P; Patro DK; Basu D; Elangovan S; Parathasarathy V
    Am J Clin Oncol; 2014 Aug; 37(4):384-90. PubMed ID: 23388556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy?
    Holscher HC; Bloem JL; van der Woude HJ; Hermans J; Nooy MA; Taminiau AH; Hogendoorn PC
    Clin Radiol; 1995 Jun; 50(6):384-90. PubMed ID: 7789022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
    Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
    Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
    Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
    Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T.
    Lee SK; Jee WH; Jung CK; Im SA; Chung NG; Chung YG
    PLoS One; 2020; 15(3):e0229983. PubMed ID: 32155203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can conventional magnetic resonance imaging at presentation predict chemoresistance in osteosarcoma?
    Kanthawang T; Wudhikulprapan W; Phinyo P; Settakorn J; Pruksakorn D; Link TM; Pattamapaspong N
    Br J Radiol; 2024 Feb; 97(1154):451-461. PubMed ID: 38308035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.
    Prabowo Y; Setiawan I; Kamal AF; Kodrat E; Labib Zufar ML
    Int J Surg Oncol; 2021; 2021():8843325. PubMed ID: 33996154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
    J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.